Medivir appoints Vice President, Research & Development Projects

02-Nov-2010 - Sweden

Medivir AB announced the appointment of Charlotte Edenius to the new position of Vice President, Research & Development Projects, effective 1 November 2010. This newly created position, with responsibility for Medivir’s project portfolio, marks another step in the direction of strategically enhancing Medivir’s R&D organisation, and accordingly, Charlotte will become a member of the company’s management.

Charlotte holds a medical degree and has a Ph.D. from the Karolinska Institute. She joins Medivir from a position as Senior Vice President and Chief Scientific Officer of Swedish pharmaceutical company Orexo AB. Charlotte’s previous positions also include Vice President and Chief Scientific Officer of Biolipox AB in 2001-2007 and various executive positions in Experimental Medicine, Clinical R&D AstraZeneca, at Södertälje, Sweden in 1995-2001.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances